Granules India Limited will convene a meeting with analysts, investors, and funds on September 28, 2026, in New Delhi. The management team is scheduled to engage with market participants to discuss business updates and strategic priorities.

The company filed an intimation with the National Stock Exchange of India and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events and corporate actions to ensure fair market participation.

Meeting Details and Compliance

The schedule for the interaction remains tentative and subject to change based on logistical considerations or availability constraints. Granules India explicitly stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during the meetings. This assurance aligns with regulatory standards to prevent selective disclosure and maintain market integrity.

Investors seeking detailed financial and operational insights can access the latest investor presentation on the company’s official website. The presentation serves as the primary source of publicly available data ahead of the face-to-face engagement.

Key Event Information

This event provides an opportunity for institutional stakeholders to gain deeper clarity on the company’s performance trajectory without accessing non-public data.

Granules India Limited promoter Dr. Krishna Prasad Chigurupati disposed of 1,72,00,000 equity shares through a block deal on September 11, 2026. The transaction represented 6.94% of the company’s total voting capital.

The sale reduced Chigurupati’s stake in the Hyderabad-based pharmaceutical firm from 31.00% to 24.06%. Prior to the transaction, he held 7,68,08,111 shares carrying voting rights.

Transaction Details

The block deal saw participation from marquee institutional investors. Buyers included Capital Group, Kotak Mahindra Life Insurance Company, ChrysCapital, Allspring, and other domestic and global entities.

Chigurupati filed the disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was submitted to the National Stock Exchange of India Limited and BSE Limited.

What the Numbers Show

The promoter’s post-transaction holding of 5,96,08,111 shares represents a significant reduction in concentration risk for institutional buyers. While the absolute stake dropped by nearly seven percentage points, Chigurupati retains control with a diluted holding of 21.85%, remaining the largest single shareholder group as no other entity was disclosed as acquiring a controlling interest in this specific transaction.